Overview
Boston-based biotech leader Alnylam joined forces with Veerless and partner Cause Consulting to implement an enterprise-wide Corporate Responsibility (CR) framework and a clear reporting strategy. Together, we engaged global stakeholders in a materiality-driven reporting and collaborative goal-setting process, centered on a common purpose and vision with Alnylam’s global CR theme “Accepting Challenges to Improve the Health of Humanity.” This theme is Alnylam’s “North Star” for CR initiatives and reporting, aligning its global teams around a single goal focused on their business, strengths, and core capabilities.
The Situation
In 2021, Alnylam turned initial materiality insights into action, recruiting Veerless and social impact consulting leader Cause Consulting to build a data-driven CR reporting strategy. That foundation has grown into a multi-year, evolving partnership that reflects increasing sophistication in ESG strategy and execution. Alnylam’s global team and strategy was already purpose driven. The challenge we faced together was aligning that purpose with stakeholder expectations and the shifting world of regulation and responsibility globally. Together, we built a CR strategy highlighting Alnylam’s unique position as an innovative top-tier biotech company, while reinforcing its values-centered identity.
The Solution
We continue to support Alnylam across four strategic focus areas:
- CR/ESG Strategy Development
Veerless and Cause Consulting collaborated to provide ongoing strategic counsel on CR and ESG planning and reporting. The company’s 2021 CR Report formally aligned with GRI and SASB standards, marking a leap in transparency. As Alnylam prepares for 2025, we’re guiding CSRD readiness to integrate regulatory requirements with strategic growth and stakeholder priorities. - Materiality Assessment
Alnylam’s CR strategy is continuously shaped by its evolving understanding of material risks and opportunities across the enterprise. Each year, we refine the process to reflect industry dynamics, stakeholder priorities, and global benchmarks. In 2025, Alnylam’s CR Steering Committee launched a full double materiality assessment in preparation for the Corporate Sustainability Reporting Directive (CSRD). This process captures stakeholder perspectives on the impact, importance, and performance of Alnylam’s material topics across the value chain. These efforts are propelling Alnylam forward as a leader in biotechnology. We don’t just gather data to check a box. We help clients turn insights into actionable intelligence, delivered in real time to drive meaningful impact.
- Reporting
Our approach to reporting brings data to life. It goes beyond regulatory requirements to share the real-world impact of Alnylam’s work. We spotlight initiatives that advance health equity, reduce environmental impact, and nurture employee passion and innovation. Through compelling vignettes and case studies, we help Alnylam connect metrics with meaning, showcasing how CR efforts reflect and amplify the company’s values. Reporting becomes not just a record of performance, but a platform for progress.
- Ongoing Implementation and Progress
We continue to work closely with Alnylam to embed ESG into day-to-day operations and long-term planning. From streamlining data systems to interpreting regulatory change and aligning teams around shared goals, we help build durable capacity in responsibility and sustainability. This is a long-term partnership focused on momentum, adaptability, and integration, ensuring Corporate Responsibility is a strategic function woven into the business.
The Impact
Since 2021, Alnylam has advanced its Corporate Responsibility program through a long-term partnership with Veerless and Cause Consulting. Our role as trusted advisors has helped ensure that ESG is no longer peripheral, it is embedded in Alnylam’s operations, strategy, and stakeholder communications.
This guidance supports Alnylam’s ability to scale innovation responsibly. As the company grows, it remains grounded in a clear sense of duty to patients, employees, and the broader community. ESG is now both a compass and a catalyst, informing decisions, reinforcing trust, and unlocking long-term value.
By pairing industry leadership with our deep strategic counsel, Alnylam is positioned to lead with integrity in a shifting ESG landscape and demonstrate what it means to grow with purpose.
Featured Project
Alnylam’s 2024 Corporate Responsibility report features strong alignment to the company’s global CR Pillars and increasingly robust data transparency.
“Working with Veerless has been more than a consultancy relationship — it’s a true partnership built on trust. Their strategic insight, adaptability, and deep understanding of the evolving ESG landscape have made them an invaluable ally in our Corporate Responsibility journey.”